PHAT
#2559
Phathom Pharmaceuticals, Inc. - Common Stock
10.9 2 USD
-0.13%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-13.40%
Monthly Change
+5.81%
6 month change
-27.44%
Year Change
+20.80%
Previous Close
12.6 1
Open
10.9 2
Low
10.9 2
High
10.9 2
Volume
96
Financials
- Market Capitalization 870.94 M
- Employee 371
- Founded 2018
- CEO N/A
- Website www.phathompharma.com
- Headquarter Delaware, United States
- FIGI BBG00P5B2S19
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-5.48
Price to sales ratio
6.91
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2535 |  GERN Geron Corporation - Common Stock | 1.42 USD | -5.33% | -1.39% | +22.41% | +6.77% | 910.96 M USD | ||
| 2558 |  TBPH Theravance Biopharma, Inc. - Ordinary Shares | 16.90 USD | -0.18% | -0.59% | +1.75% | +17.77% | 871.25 M USD | ||
| 2561 |  DSGN Design Therapeutics, Inc. - Common Stock | 13.86 USD | -8.76% | -7.41% | +24.98% | +248.24% | 865.65 M USD | ||
| 2588 |  REPL Replimune Group, Inc. - Common Stock | 9.94 USD | -9.55% | -14.38% | +12.83% | -13.34% | 834.41 M USD |
Frequently asked questions about Phathom Pharmaceuticals, Inc. - Common Stock
What is the Phathom Pharmaceuticals, Inc. - Common Stock stock price today?
The current price of Phathom Pharmaceuticals, Inc. - Common Stock (PHAT) is 10.92. Over the past 24 hours, the stock has changed by -13.40%. Follow the PHAT chart for real-time price dynamics.
What is the stock ticker of Phathom Pharmaceuticals, Inc. - Common Stock?
Phathom Pharmaceuticals, Inc. - Common Stock trades under the ticker PHAT. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Phathom Pharmaceuticals, Inc. - Common Stock stock going up?
PHAT has changed by -5.37% over the last week, +5.81% over the last month, and +20.80% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Phathom Pharmaceuticals, Inc. - Common Stock net income for the last quarter?
Phathom Pharmaceuticals, Inc. - Common Stock reported net income of -30.37 M for the last quarter. The previous quarter showed -21.15 M, which means net income changed by -43.60%.
How many employees does Phathom Pharmaceuticals, Inc. - Common Stock have?
As of the latest available data, Phathom Pharmaceuticals, Inc. - Common Stock has 371 employees. Workforce size can provide additional context about the company's scale and operations.
What is Phathom Pharmaceuticals, Inc. - Common Stock EBITDA?
Phathom Pharmaceuticals, Inc. - Common Stock EBITDA is -15.37 M, and its EBITDA margin is -26.36%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Phathom Pharmaceuticals, Inc. - Common Stock stock?
You can buy Phathom Pharmaceuticals, Inc. - Common Stock (PHAT) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Phathom Pharmaceuticals, Inc. - Common Stock stock?
Investing in Phathom Pharmaceuticals, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the PHAT chart and related analysis on metatrader.com as part of your research.